4//SEC Filing
Stonehouse Jon P 4
Accession 0001127602-24-029948
CIK 0000882796other
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 4:01 PM ET
Size
13.6 KB
Accession
0001127602-24-029948
Insider Transaction Report
Form 4
Stonehouse Jon P
DirectorPresident & CEO
Transactions
- Tax Payment
Common Stock
2024-12-19$7.39/sh−14,010$103,534→ 1,449,109 total - Gift
Common Stock
2024-12-20−20,000→ 1,429,109 total - Gift
Common Stock
2024-12-20+10,000→ 30,000 total(indirect: By Trust) - Award
Emp. Stock Option (Right to Buy)
2024-12-19+750,250→ 750,250 totalExercise: $7.39From: 2025-12-19Exp: 2034-12-19→ Common Stock (750,250 underlying) - Award
Common Stock
2024-12-19+362,100→ 1,463,119 total - Gift
Common Stock
2024-12-20+10,000→ 30,000 total(indirect: By Trust)
Footnotes (4)
- [F1]Annual award of Restricted Stock Units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant.
- [F2]Represents shares withheld by the Issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the Reporting Person.
- [F3]On December 20, 2024, the Reporting Person gifted 10,000 shares held directly by him to each of the Samuel Stonehouse Irrevocable Trust and the Caroline Stonehouse Irrevocable Trust.
- [F4]Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001385496
Filing Metadata
- Form type
- 4
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 4:01 PM ET
- Size
- 13.6 KB